Evigrade
Major

Fluconazole × Warfarin

Antifungals, triazole derivatives×Vitamin K antagonist anticoagulants

Mechanism

Fluconazole inhibits CYP2C9, the main enzyme of S-warfarin (the more active isomer). INR rises to 8–12 with risk of major bleeding: gastrointestinal, intracranial, retroperitoneal.

Symptoms

By days 3–5: gum and nose bleeding, petechiae, haematuria, bloody stool. INR above 6 without clinical bleeding still requires action.

Management

If fluconazole is required, reduce warfarin by 25–50% from day 1 and check INR on days 3 and 7. Short courses (3 single doses) – INR check on day 5. After fluconazole withdrawal, retitrate warfarin upward.

Check the full regimen, not just this pair

Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.

Open checker

Sources

All interactions